Ekspresi Imunohistokimia Ki-67 pada Tumor Payudara tikus Wistar yang Diinokulasi Kanker Terinduksi Benzo(α)pyrene dengan Pemberian Ekstrak Benalu Teh

DAFTAR RUJUKAN
1. Direktorat Jenderal Pelayanan Medik Depkes RI, Badan Registrasi Kanker
Perhimpunan Dokter Spesialis patologi Indonesia. Data Histopatologik.Yayasan
Kanker Indonesia, 2001.
2. Jwrt, Stanley J. Breast cancer overview, incidence and prevalence .available from
http://www.oncologychannel.com/breastcancer/index.shtml:Des;2007
3. Mark JR, Humphrey PA, Wu K, et al. Overexpression of p53 and Her-2/neu
proteins as prognostic markers in early stage breast cancer. Annals of Surgery.
1994;219:332-341.
4. Lester, Susan C. The breast. In : kumar V, Abbas AK, fausto N, editors. Robbins
and Cotran Pathologic Basis of Disease. 7th edition. Elsevier;2005:1119-1151.
5. Cell cycle related proteins in hyperplasia of usual type in breast specimens of
patients with and without breast cancer : (cited 2011 jan 15). Available from :
hhtp://www.biomedcentral.com/147-2121/7/29.
6. Schluter C, Duchrow M, Wohlenberg C, Becker MHG, Key G, Flad HD, et al.
The cell proliferation-associated antigen of antibody Ki-67: a very large,
ubiquitous nuclear protein with numerous repeated alements, representing a new
kind of cell cycle-maintaining protins. J cell boil 1993 Nov; 123(3):p 513-522.
7. Puay HT, Boon HB, Yip G, Selvarajan S, tan P, Wu J, et al.
Immunohistochemical detection of Ki67 in breast cancer correlates with
transcriptional regulation of genes related to apoptosis and cell death. Modern

pathol (2005) 18 2004 Nov 19:374-381.
8. Ellis.IO, Schnitt SJ. Invasive breast carcinoma. In: Tavassoli FA, Devilee P.
WHO Classification ot Tumours Pathology and Genetics of Tumours of the
Breast and Female Genital Organs. Lyon: IARC Press; 2003. p.13-103.
9. Mahardini T, Renawati, Yulistia A. Parameter Polycyclic Aromatic Hydrocarbons
(PAHs) dalam Standarisasi Produk Pangan. Balai Besar Industri Agro Deprin,
Bogor.
10. Agency for Toxic Subtances and Desease Regstry (ATSDR), 1995,
ToxicologicalProfile for Polycyclic Aromatic Hydrocarbons (PAHs). Atlanta,
GA: U.S.Departement of Health and Human Services, Public Health Services.
11. Elisabeth, dkk., Polycyclic Aromatic Hydrocarbon (PAH): Kaitannya dengan
minyak sawit dan kesehatan, dalam warta PPKS (Pusat Penelitian KelapaSawit),
Medan. 2000.
50
Universitas Sumatera Utara

12. Juliyarsi I, Melia S. Dadih susu sapi mutan lactococcus lactis sebagai food
healthy dalam menghambat kanker. Artikel Penelitian. Fakultas Peternakan
Universitas Andalas, Padang. 2007. hal:1-25.
13. Rosai J. Rosai and Ackerman’s Surgical Pathology : Breast. 9th edition. Mosby;

2004.1764-1835.
14. Rosmarilin H. Anti-cancer activity of local alpinia galangal L (SW) rhizome
extracts on cancer cell line of human and mice transplanted with primary tumor
cell. USU reporitary 2006 (cited 2007 feb 14). Available from:
http://library.usu.ac.id/download/fp/D0300608.pdf
15. Ohashi K, Winarno H, Mukai M. Indonesian medicinal plants XXV: cancer cell
invasion inhibitory effects of chemical constituents in the parasitic plant Scurrula
artropurpurea (Loranthaceae). Chem Pharm. Bull 2003;51:343-5.
16. Muwarni R. Indonesian tea mistletoe (Scurrula oortiana ) stem extract increases
tumor cell sensitivity to tumour necrosis factor alpha (TNF alpha). Phytotherapy
Research. Phytother. Res 2003:17:407-9. [cited June 17, 2005]. Available from
URL : http://www.interscience.wiley.com.
17. Matsunaga K. Legionella pneumophila replication in macrophages inhibited by
selective immunomodulatory effects on cytokines formation by epigallocathecin
gallate, a major substance from of tea cathecin. Infect and Immunity
2001;69(6):3947-3953.
18. Noreen Y, Serrano G, Perera P, Bohlin L. Flavan-3-ols isolated from some
medicinal plants inhibiting COX-1 and COX-2catalyzed prostaglandin
biosynthesis.
1998.[cited

June
17,
2005].
Available
from
URL:http://www.fkogserver. bmc.uu.se/info/p1998.html
19. Sulistyo H. Inhibisi aktivitas proliferasi sel dan perubahan histopatologik
epithelial mukosa nasofaring mencit C3H dengan pemberian ekstrak benalu teh.
Tesis Program pasca sarjana Universitas Diponegoro. Semarang. 2008.
20. Anonymus.
Kanker
Payudara.
Farmasia.2008.
farmasiaunfari.blogspot.com. (cited 10 September 2012)

Available

at:

21. Anderson. Female Reproductive System. Volume 6. Churchill Livingstone. 1991:

208-218.
22. The global burden of cancer: Available from: http://www.global.iarc.fr. (cited
2011jan12).

51
Universitas Sumatera Utara

23. Benzoalphapyrene. Wikipedia.Available from:
http://en.wikipedia.org/wiki/Benzo(a)pyrene.

(cited

12

Januari

2012)

24. Public health goal for benzo(a)pyrene in drinking water, December 1977:1-42
25. Caussens, L.M. and Werb, Z. Inflammation and Cancer. Nature 420, 2002:860867.

26. Sachs, R.K., Chan, M., Hlatky, L., and Hahnfeldt, P. Modeling Intercellular
Interactions during Carcinogenesis. Radiat. Res. 2005;164:324-331.
27. Edsell. RD. Benzo(a)pyrene Regulated with Coal Tar PitchVolatiles.Occupational
Safety
and
Health
Administration
(ASHA),
US
Dept.
Of
labor.1986. http://www.osha-sle.gov/Osh.Doc/Interp_data/119860407.html. cited:
12 Juni 2011.
28. Lamson DW, Brignall MS. Antioxidants and cancer III: quercetin. Altern Med
Rev. 2000;5(3):196-208.
29. Fernandez T, cerda Z. immunobiological features of the galactoside lectin L-Lc
isolated from the Argentine mistletoe ligaria cuneifolia. 2003. Available from :
http://www.nchi.nlm.nih.gov/entrez/query.fcgi?pubmed&cmd?Display&dopt?pub
medpubmed&fromuid:12576206
30. Hargono D. Inhibisi aktivitas biologik infusum benalu teh (Scurrulla

atropurpurea) (bl) danser terhadap aktivitas system imun pada mencit. 1998.
Available from : http://digilib.litbang.depkes.go.id/go.php/id=jkpkb cited:
Agustus 2011.
31. Davehat L, tomasi s, Fontanel D, boustie J. flavonols from Scurrulla ferruginea
danser
(loranthaceae).2002.
Available
from
:
http://www.nchi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd+Display&dopt
pubmed_pubmed&from_uid:12562100 cited: September 2011.
32. Kresno SB. Imunologi: diagnosis dan prosedur laboratorium.Ed 4.Jakarta: Balai
Penerbit Fakultas Kedokteran Universitas Indonesia. 2001:14-101.
33. Abbas AK, Lichtman AH, Fober JS. Cellular and molecular immunology,4thed.
Philadelphia: Saunders.2000:384-403.
34. Brakenhielm, Ebba. Angiogenesis in obesity and cancer. 2003. Available from :
http://www.diss.kib.ki.se/2003/91-7349-578-6/ cited: Juli 2011
35. Ki-67 (biology). From Wikipedia, the free encyclopedia.
http://en.wikipedia.org/wiki/Ki-67_(Biology) cited: Februari 2012.


From

:

52
Universitas Sumatera Utara

36. Urruticoechea A, Smith I.E, Dowsett M. Proliferation marker Ki-67 in early
breast cancer. Journal of Clinical Oncology. 2005;23(28):7212-7220.
37. Sudigdo S, Sofyan I. Dasar-dasar metodologi penelitian klinis. Edisi 3. Jakarta.
ISBN. 2008.
38. Federer, W.Y. Experimental design, theory and application. New York,
Mac.Millan. 1963. p:544.
39. Jonat W, Arnold N. Is the ki-67 labelling index ready for clinical use?. Annals of
Oncology. 2011:22(3):500-502.
40. Santoso, S. Buku Latihan SPSS Statistik Non Parametrik. Penerbit PT Elex Media
Komputindo Kelompok Gramedia. Jakarta.2001:127-135.
41. Sulaiman, W. Statistik Non Parametrik Contoh Kasus dan Pemecahannya dengan
SPSS. Edisi Pertama. Penerbit ANDI, Yogyakarta.2003: 29.
42. Swann B.J and Smyth J.M. Immune surveillance of tumors. The Journal of

Clinical Investigation.2007;117(5):1137-1146.
43. Urruticoechea A. Smith I.A and Dowsett M. Proliferation marker Ki-67 in early
breast cancer. Journal of Clinical Oncology.2005;23(28):7212-7220.

53
Universitas Sumatera Utara